Is ZTS Worth Buying in 2026?

ZOETIS INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether ZOETIS INC. (ZTS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 44 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-7.01% over 10 days); weak 1-year return of -52.9%; 3-month momentum negative (-32.6%). Currently 52.9% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

ZTS is trading below its 200-day MA ($122.24) — a key warning sign the longer-term trend is under pressure. An RSI of 44.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -52.9% compares to +22.9% for SPY (trailed the market by 75.7%). The current 52.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $4,713 today
vs. S&P 500 (SPY) — same period trailed market by 75.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($122.24)
Above 50-day MA ($97.48)
RSI(14) neutral zone (30–70) — currently 44.2
Positive return (-52.9%)
!Within 10% of period high (−52.9%)
Period Range $79.57
$72.38 $168.83
RSI (14) 44.2
0 · OversoldOverbought · 100

Key Metrics

Price$79.57
Period Return-52.9%
Period High$168.83
Period Low$72.38
Drawdown−52.9%
MA-50$97.48
MA-200$122.24
RSI (14)44.2
Avg Volume (30d)8.8M
vs. SPYtrailed by 75.7%
Return Rank#1085 of 1246

Trade ZTS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers